Innoviva Inc news

   Watch this stock
Showing stories 1 - 10 of about 91   

Articles published

INVA 11.13 +0.20 (1.83%)
price chart
Innoviva: On Track To Buy Back The Whole Company
I have already reviewed the performance of GSK's (NYSE:GSK) new respiratory drugs in another article, so this one will focus on the issues specific to its development partner Innoviva (NASDAQ:INVA) (formerly called Theravance). Innoviva ended 2015 with ...
Innoviva Inc Gains on Upbeat Quarterly Earnings  Bidness ETC
Innoviva Inc. (NASDAQ:INVA) Fourth quarter results  Inside Trade
Analysts Set Innoviva Inc (NASDAQ:INVA) PT at $11.20
Innoviva logo Shares of Innoviva Inc (NASDAQ:INVA) have received a consensus recommendation of “Hold” from the six ratings firms that are covering the firm, MarketBeat.
Innoviva Inc (INVA) Lifted to Hold at Zacks Investment Research
Innoviva logo Innoviva Inc (NASDAQ:INVA) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a research note issued on Saturday, Marketbeat.
Innoviva Inc (INVA) Upgraded to Hold by Zacks Investment Research  Intercooler Financial
Innoviva: What Happens When Generic Advair Hits The Market?
While Advair started its decline, GSK launched a portfolio of successor products, among which Breo, partnered with Innoviva, is presumably the most important one. However, Breo's launch was slower than expected (by the market, not by management), and ...
Theravance (THRX) Changes Name, Ticker to Innoviva (INVA)
Theravance, Inc. (NASDAQ: THRX) announced that it changed its name to Innoviva, Inc., effective January 7, 2016. In addition to Innoviva's new name, the company has also unveiled a new corporate identity and website, available at www.
Theravance, Inc. Announces Name Change to Innoviva, Inc.  EIN News (press release)
Innoviva Inc (INVA) Set to Announce Quarterly Earnings on Wednesday
Innoviva logo Innoviva Inc (NASDAQ:INVA) is scheduled to be announcing its Q415 earnings results on Wednesday, February 3rd.
Analysis and Innoviva Inc (INVA) Earnings Review
Innoviva Inc. INVA (US: Nasdaq)
Innoviva Inc. INVA (U.S.: Nasdaq). search. View All companies. AT CLOSE 4:00 PM EST 02/04/16. $11.10 USD; 2.00 21.98%.
Innoviva Inc (NASDAQ:INVA) Receives Consensus Rating of "Hold" from Brokerages
Innoviva logo Shares of Innoviva Inc (NASDAQ:INVA) have earned an average recommendation of “Hold” from the six analysts that are currently covering the stock, AnalystRatings.
Analysts Set Innoviva Inc (NASDAQ:INVA) Price Target at $11.20
Innoviva logo Innoviva Inc (NASDAQ:INVA) has earned an average recommendation of “Hold” from the six research firms that are presently covering the stock, Analyst Ratings Net reports.
Tech Top Gainers- Innoviva, Inc. (NASDAQ:INVA), 3D Systems Corporation (NYSE ...
Innoviva, Inc. (NASDAQ:INVA) climbs 21.98% to close at $11.10 as 2.31 Million shares changed hands in regular trading session.